Annotation Detail for CA5A
Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa00910 | Nitrogen metabolism |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CA5A mRNA | affects expression | 21346803
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of CA5A protein | affects expression | 20106945
|
D001959 |
Bromates |
Bromates results in decreased activity of CA5A protein | decreases activity | 15664814
|
D002254 |
Carbonates |
Carbonates results in decreased activity of CA5A protein | decreases activity | 15664814
|
C022842 |
chloric acid |
chloric acid results in decreased activity of CA5A protein | decreases activity | 15664814
|
D004052 |
Diethylnitrosamine |
Diethylnitrosamine results in decreased expression of CA5A mRNA | decreases expression | 19638242
|
D007452 |
Iodates |
Iodates results in decreased activity of CA5A protein | decreases activity | 15664814
|
C044659 |
molybdate |
molybdate results in decreased activity of CA5A protein | decreases activity | 15664814
|
D017942 |
Nitric Acid |
Nitric Acid results in decreased activity of CA5A protein | decreases activity | 15664814
|
C494474 |
perchlorate |
perchlorate results in decreased activity of CA5A protein | decreases activity | 15664814
|
C037192 |
potassium periodate |
potassium periodate results in decreased activity of CA5A protein | decreases activity | 15664814
|
C025349 |
sodium metasilicate |
sodium metasilicate results in decreased activity of CA5A protein | decreases activity | 15664814
|
C005741 |
sulfamic acid |
sulfamic acid results in decreased activity of CA5A protein | decreases activity | 15664814
|
D014303 |
Trinitrotoluene |
Trinitrotoluene affects the expression of CA5A mRNA | affects expression | 21346803
|
C045951 |
tungstate |
tungstate results in decreased activity of CA5A protein | decreases activity | 15664814
|
D014638 |
Vanadates |
Vanadates results in decreased activity of CA5A protein | decreases activity | 15664814
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Trinitrotoluene |
4.21 | 7525203 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.85 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
3.92 | 19052882 19061943 16434500 17620307 17162532 18056438 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.24 | 17474063 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.60 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
4.60 | 12619106 21507988 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
4.60 | 3581430 18506893 20007298 16569478 20101231 16935385 11831363 18210153 18785209 19919837 18971187 20214788 3084413 19701751 21159647 18788625 20432363 10672840 10737359 19208518 20935162 16878318 19383236 16288022 18494052 17173139 19394651 17055752 18393292 19171122 20084675 17138121 16779866 19539802 18691550 17978847 17428255 20512989 18056438 19418558 19822196 16328049 19519916 20727157 19052882 18665156 20524982 18978308 17162532 16698587 19335982 16830150 17761372 16502159 16681979 16540662 19107877 20514400 16807293 |
MESH:D002386 |
Cataract |
|
Trinitrotoluene |
3.87 | 14694615 15817613 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
2.86 | 21159647 17174075 7505956 2727394 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.69 | 19052882 |
MESH:D000013 |
Congenital Abnormalities |
|
Trinitrotoluene |
4.40 | 15095906 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
11.27 | 18551238 |
MESH:D003490 |
Cyanosis |
|
Trinitrotoluene |
11.27 | 18551238 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.19 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.36 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
6.36 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trinitrotoluene |
6.36 | 18551238 21346803 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.15 | 16302075 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
3.19 | 21071580 20387270 |
MESH:D006042 |
Goiter |
|
perchlorate |
5.31 | 18801409 |
MESH:D006529 |
Hepatomegaly |
|
Trinitrotoluene |
4.25 | 15817613 |
MESH:D007248 |
Infertility, Male |
|
Trinitrotoluene |
3.68 | 12150543 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
2.38 | 18785209 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
2.98 | 16705839 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.82 | 20032147 19638242 18407596 18522880 18665156 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.10 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
4.64 | 18177683 2125692 15890375 9163691 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
4.64 | 18648771 20583210 12112319 19850985 18977376 19255062 21278145 21071580 19426721 20434301 20101389 19996281 19499222 19294768 19638242 2862719 19254457 21167192 20137499 19551842 12771043 19642983 15175105 19256749 19690152 20118626 20501860 20492335 18754104 20405173 2422723 16942905 19833225 18644402 19812893 21047994 19427195 18978307 10737359 9163691 20452335 19073162 19090486 15885732 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
6.00 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
6.00 | 19009564 19004024 16267830 17942915 19539802 18544905 17854601 18164116 18308698 3124819 19519916 18775883 16842330 19126423 18282651 18079962 2563599 18253720 9362446 17174075 18093689 21159647 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
2.49 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.49 | 20970405 6695378 21163286 20512841 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.75 | 18551238 |
MESH:D009336 |
Necrosis |
|
Trinitrotoluene |
10.75 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.57 | 3581430 9029167 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.34 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.15 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.23 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
Trinitrotoluene |
9.23 | 12819281 17852074 14694615 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.42 | 16540662 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.55 | 2563599 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.20 | 18551238 |
MESH:D012640 |
Seizures |
|
Trinitrotoluene |
6.20 | 18551238 |
MESH:D013163 |
Splenomegaly |
|
Trinitrotoluene |
5.21 | 15817613 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.75 | 18456281 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
2.98 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
2.29 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.33 | 10091137 |
Pathway ID |
Pathway Name |
---|
KEGG:00910 |
Nitrogen metabolism |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB00909 |
antagonist |
Zonisamide |
Antioxidants;Anticonvulsants |
DB01194 |
inhibitor |
Brinzolamide |
Carbonic Anhydrase Inhibitors;Antiglaucomic Agents;Ophthalmics |
DB03385 |
- |
4-Methylimidazole |
|